Erythropoietin Improves Effects of Mesenchymal Stem Cells in Experimental Endotoxemia
Journal Title: Journal of Advances in Medicine and Medical Research - Year 2016, Vol 13, Issue 10
Abstract
Aims: Sepsis is a leading cause of mortality in intensive care units. Development of new strategies such as the therapy with mesenchymal stem cells (MSC) appears beneficial for the treatment of sepsis. In this study we evaluated anti-septic effects of rat MSCs and recombinant erythropoietin (EPO) in a rat experimental model of endotoxemia. Study Design: Controlled in vitro and in vivo studies. Place and Duration of Study: Federal Research Clinical Center of FMBA of Russia, Moscow, Russia, between June 2014 and May 2015. Methodology: Endotoxemia was induced by intraperitoneal administration of bacterial lipopolysacharide (LPS). The animals were then treated either with allogeneic MSCs alone, with recombinant EPO alone, or with a combination of EPO and MCS. After 3 days, the animals were euthanized, and a pathology study of their liver, spleen, thymus, lung, and kidney was performed. The serum levels of IL-1β, IL-6, and TNF-α were quantified. A histochemical analysis of splenic and thymic expression of CD3, CD57, p53, and Bcl-2 was performed. Results: Essential positive effects of the combined MSC-EPO treatment were observed: 1) The animals treated with MSCs and EPO had the lowest serum concentrations of IL-1β in respect to that of the rats treated with LPS alone (58 ± 22 pg/mL vs. 155±90 pg/mL, P = .01); 2) The treatment of endotoxemic rats with a combination of MSCs and EPO also caused production of the anti-apoptotic factor Bcl-2, while its expression was markedly down-regulated in the other groups of animals; 3) In the MSC + EPO group, the degree of interstitial pulmonary edema was the lowest as compared to the other groups, and a minimal renal injury was detected. Conclusion: These findings suggest that EPO generally improves anti-inflammatory and anti-apoptotic effects of MSCs injected in the acute phase of experimental endotoxemia.
Authors and Affiliations
Alexander V. Averyanov, Anatoly G. Konoplyannikov, Fedor G. Zabozlaev, Anastasia V. Sorokina, Mikhail A. Konoplyannikov, Vladimir P. Baklaushev, Robert I. Khabazov
Keywords
Related Articles
- EP ID EP340494
- DOI 10.9734/BJMMR/2016/23761
- Views 83
- Downloads 0
Patients with Abdominal Aortic Aneurysm Demonstrate Higher Levels of Non-cholesterol Sterol Markers of Endogenous Cholesterol Synthesis
Aims: To establish the levels of selected non-cholesterol sterols in patients with abdominal aortic aneurysm (AAA) and to compare them with levels in non-AAA patients treated for lipid metabolism disorder. To compare the...
Prevalence of Down Syndrome in Western India: A Cytogenetic Study
Aim: To study the prevalence of Down syndrome by conventional chromosome analysis and G-banded karyotyping. Materials and Methods: A retrospective analysis was performed on the case records of2750 paediatrics patients, o...
Solitary Fibrous Tumor of Head & Neck Region: Problems in Diagnosis Due to “Borderline” Features
Aims: To report SFT in a 45 years male who had a lobulated tumor in neck for longest duration of 18 years with borderline histomorphology. Presentation of Case: The case discussed is of a forty-five year old Indian man w...
Bone Marrow Mast Cell Density Correlates with Circulating Biomarkers of Bone Disease in Multiple Myeloma
Aims: There is increased mast cell density (MCD) in multiple myeloma (MM) bone marrow (BM) that is correlated with advanced disease stage. Mast cells (MCs) produce various mediators promoting MM growth and bone metabolis...
Pseudo-hypoparathyroidism Coexistent with Systemic Sclerosis: A Rare Case Report
Background: Systemic sclerosis is a chronic autoimmune inflammatory disease with wide-spread fibrosis of the skin and internal organs. The hypoparathyroidism associated with systemic sclerosis is infrequent and rarely re...